Researchers have launched a new campaign called AUVI-Q Speaks Up™ to improve awareness and preparedness for severe allergic reactions, particularly anaphylaxis. This initiative, led by Kaléo, aims to foster open conversations within the allergy community and provide practical resources for individuals of all ages, from infants to adults. The campaign emphasizes the importance of recognizing anaphylaxis symptoms and responding quickly, as studies show that only about 26% of people experiencing anaphylaxis receive the necessary epinephrine before professional medical help arrives.

This is particularly significant for the approximately 32 million Americans living with food allergies, as effective management can lead to better outcomes. The AUVI-Q auto-injector, which features voice guidance to assist users during emergencies, is designed to be user-friendly. It can help individuals act decisively when every second counts, potentially reducing the risk of severe complications from allergic reactions. The campaign encourages people to be proactive about their allergy management, ensuring they have a plan and the right tools at hand.

The AUVI-Q Speaks Up campaign is part of a broader effort to bridge the gap between clinical guidelines and real-life responses to allergic emergencies. While the campaign is based on strong community input and usability studies, it is still in the early stages of implementation. This means that while the initiative is promising, more extensive research and real-world application will be necessary to fully evaluate its effectiveness in improving emergency responses among allergy sufferers.

If you or someone you know has food allergies, consider discussing an allergy management plan with your healthcare provider. Carrying two AUVI-Q devices and knowing how to use them can make a critical difference in an emergency.

Source: globenewswire.com